News Formal

The FDA recently gained more leverage over pharmaceutical companies. Will it use it?

  • 📰 NPRHealth
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

United States News News

United States United States Latest News,United States United States Headlines

The U.S. Food and Drug Administration late last year got more leverage over pharmaceutical companies that received accelerated approvals for their drugs. How will the agency use its new powers?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 144. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Not under the Biden administration.

Worked on TecentriqHCP startup in NSCLC for North America while at PPDCRO at the end of 2014. US_FDA approved it by 2019. Wrote so many reports for GO29436, 437, 537, 432, 431, 527 got RSI. PPD wrongfully terminated me 2017 after they injured fly_BUR in 2016. You’re welcome

United States United States Latest News, United States United States Headlines